Patient-Derived Organoids as a Platform to Decipher and Overcome Radioresistance: From the Tumor Microenvironment to Radiosensitizer Discovery

Patient-derived organoids (PDOs) preserve patient genotypes and 3D architecture, offering a useful platform to investigate mechanisms of radioresistance and test radiosensitizers. We outline an end-to-end workflow—model establishment, multi-omics profiling, pharmacologic screening, and in vivo confi...

詳細記述

書誌詳細

主要な著者:	Dashan Yin, Xiujuan Hong, Xiaoqi Wang, Wenjia Ding, Chenli Wang, Jin Qian, Yi Zhou, Chuan Sun, Zhibing Wu
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2025-12-01
シリーズ:	Current Oncology
主題:	patient-derived organoids (PDOs) radioresistance radiosensitizers radiotherapy (RT) tumor microenvironment (TME) cancer stem cells (CSCs)
オンライン･アクセス:	https://www.mdpi.com/1718-7729/32/12/680
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!